APA

McClelland G. A., Stubbs R. J., Fix J. A., Pogany S. A. & Zentner G. M. (19911118). Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. : Pharmaceutical research.

Chicago

McClelland G A, Stubbs R J, Fix J A, Pogany S A and Zentner G M. 19911118. Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. : Pharmaceutical research.

Harvard

McClelland G. A., Stubbs R. J., Fix J. A., Pogany S. A. and Zentner G. M. (19911118). Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. : Pharmaceutical research.

MLA

McClelland G A, Stubbs R J, Fix J A, Pogany S A and Zentner G M. Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. : Pharmaceutical research. 19911118.